Liver cancer is a global health challenge, causing a significant social-economic burden.
Hepatocellular carcinoma (HCC) is the predominant type of primary liver cancer, which is …

Simple Summary In recent years, the genetic landscape of hepatocellular carcinoma (HCC)
has been explored, identifying TERT promoter, CTNNB1, and TP53 as the most frequent …

Simple Summary Telomerase reverse transcriptase (TERT) mutations are the most frequent
genetic alterations in hepatocellular carcinoma (HCC). However, integrative analysis studies …

Introduction: It remains unclear whether TERT promoter mutation (TERT C228T) in serum
cell-free DNA (cfDNA) is useful for the diagnosis of hepatocellular carcinoma (HCC) in …

Hepatocellular carcinoma (HCC) is the most common type of liver cancer with a high death
rate in the world. The molecular mechanisms related to the pathogenesis of HCC have not …

Revamping the current biomarker landscape of hepatocellular carcinoma (HCC) with cell-
free DNA (cfDNA) could improve overall outcomes. The use of commercially available …

Hepatocellular carcinoma (HCC) is one of the most prevalent forms of cancer worldwide.
Therefore, it is essential to diagnose and treat HCC patients promptly. As a novel discovery …

Background Liquid biopsies, particularly those involving circulating tumor DNA (ctDNA), are
rapidly emerging as a non-invasive alternative to tumor biopsies. However, clinical …

Purpose Liquid biopsy has emerged as a promising tool for minimally invasive and accurate
detection of various malignancies. We aimed to apply molecular barcode sequencing to …

Transarterial chemoembolization (TACE) is used to treat patients with unresectable
hepatocellular carcinoma (HCC). We evaluated the clinical impact of a‐fetoprotein (AFP) …